Cargando...
Heat Shock Proteins: Conditional Mediators of Inflammation in Tumor Immunity
Heat shock protein (HSP)-based anticancer vaccines have undergone successful preclinical testing and are now entering clinical trial. Questions still remain, however regarding the immunological properties of HSPs. It is now accepted that many of the HSPs participate in tumor immunity, at least in pa...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Frontiers Research Foundation
2012
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3342006/ https://ncbi.nlm.nih.gov/pubmed/22566956 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2012.00075 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|